Double maintains 3 strategies that include AVDL - Avadel Pharmaceuticals Plc
Current Value
$9.851 Year Return
Current Value
$9.851 Year Return
Yahoo
Key Insights Given the large stake in the stock by institutions, Avadel Pharmaceuticals' stock price might be...
SeekingAlpha
Harmony Biosciences continues to deliver strong sales and earnings growth, driven by its flagship drug WAKIX and a potentially promising pipeline. Learn more on HRMY stock here.
Yahoo
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation (ODD) from the U.S. Food & Drug Administration (FDA) for the treatment of Idiopathic Hypersomnia (IH). Specifically, ODD was granted based on the plausible hypothesis that LUMRYZ may be clinically superior to the same drug(s) already approved for the same indica
Finnhub
Avadel Pharmaceuticals PLC: * AVADEL PHARMACEUTICALS RECEIVES ORPHAN DRUG DESIGNATIONFROM FDAFOR LUMRYZ™ FOR EXTENDED-RELEASE ORALSUSPENSION FOR THE TREATMENT OF IDIOPATHIC...
Yahoo
Avadel Pharmaceuticals plc (NASDAQ:AVDL) announced it will present 14 new abstracts, including four oral presentations, at SLEEP 2025, highlighting significant advances for LUMRYZ, its once-at-bedtime sodium oxybate treatment for narcolepsy. Interim results from the real-world REFRESH study showed that patients switching from twice-nightly oxybate to LUMRYZ experienced clinically meaningful improvements in excessive daytime sleepiness (EDS), […]
Yahoo
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – – Data reflecting the therapeutic results of LUMRYZ treatment in people with narcolepsy across clinical as well as real-world settings will be presented – DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AV
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 39.71% | $4.89B | 0.35% |
XPH | 37.25% | $153.36M | 0.35% |
IBB | 36.48% | $5.23B | 0.45% |
GNOM | 35.01% | $44.34M | 0.5% |
PBE | 34.75% | $229.19M | 0.58% |
IWC | 34.48% | $813.58M | 0.6% |
IWO | 33.77% | $11.46B | 0.24% |
PTH | 33.75% | $104.10M | 0.6% |
ARKG | 32.96% | $980.60M | 0.75% |
IWM | 32.80% | $62.41B | 0.19% |
CGDG | 32.75% | $2.42B | 0.47% |
VTWO | 32.65% | $12.36B | 0.07% |
BBH | 32.39% | $334.99M | 0.35% |
DGS | 32.33% | $1.63B | 0.58% |
PINK | 32.22% | $131.18M | 0.5% |
EWX | 31.98% | $693.68M | 0.65% |
VSS | 31.96% | $9.04B | 0.07% |
ISCG | 31.78% | $673.24M | 0.06% |
AOM | 31.78% | $1.50B | 0.15% |
IFRA | 31.71% | $2.51B | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -20.83% | $107.77M | 0.59% |
BTAL | -18.96% | $298.87M | 1.43% |
VIXY | -18.88% | $153.01M | 0.85% |
CLIP | -15.98% | $1.50B | 0.07% |
GBIL | -10.11% | $6.05B | 0.12% |
USDU | -9.63% | $165.88M | 0.5% |
ULST | -9.02% | $663.99M | 0.2% |
IBTF | -8.77% | $2.07B | 0.07% |
IVOL | -8.47% | $358.39M | 1.02% |
XHLF | -7.57% | $1.64B | 0.03% |
CTA | -6.16% | $1.09B | 0.76% |
TBLL | -6.07% | $2.26B | 0.08% |
BSMW | -5.74% | $102.07M | 0.18% |
BILZ | -4.59% | $839.99M | 0.14% |
UUP | -4.53% | $209.44M | 0.77% |
SHYM | -3.46% | $324.05M | 0.35% |
GSST | -3.39% | $896.41M | 0.16% |
AGZ | -3.38% | $607.70M | 0.2% |
TFLO | -3.10% | $6.97B | 0.15% |
CANE | -2.90% | $10.08M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CORN | -0.29% | $47.42M | 0.2% |
XBIL | 0.31% | $782.51M | 0.15% |
BIL | -0.38% | $44.07B | 0.1356% |
SOYB | 0.49% | $25.66M | 0.22% |
BSCP | -0.53% | $3.37B | 0.1% |
SMB | -0.55% | $272.68M | 0.07% |
FMF | -0.61% | $157.50M | 0.95% |
SHYD | 0.64% | $322.63M | 0.35% |
JMST | 0.74% | $3.84B | 0.18% |
IBMP | 0.77% | $541.08M | 0.18% |
FXY | -0.78% | $857.17M | 0.4% |
IBTG | -0.78% | $1.94B | 0.07% |
DUSB | 0.94% | $1.26B | 0.15% |
UTWO | -1.09% | $374.41M | 0.15% |
KCCA | -1.18% | $93.93M | 0.87% |
MSOS | -1.40% | $307.59M | 0.77% |
LDUR | 1.49% | $913.73M | 0.5% |
SHV | -1.51% | $20.36B | 0.15% |
XONE | -1.55% | $634.70M | 0.03% |
BUXX | 1.72% | $304.62M | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRNX | 40.45% | $3.03B | -32.34% | 0.00% |
IGMS | 40.13% | $76.35M | -84.28% | 0.00% |
ROOT | 40.11% | $2.49B | +244.56% | 0.00% |
RVMD | 39.15% | $7.60B | +2.00% | 0.00% |
OSPN | 38.39% | $630.80M | +22.86% | 1.47% |
NNOX | 36.72% | $344.95M | -30.46% | 0.00% |
QTRX | 36.55% | $258.60M | -62.52% | 0.00% |
VNT | 36.04% | $5.43B | -5.50% | 0.27% |
ITRI | 35.51% | $5.59B | +13.32% | 0.00% |
GEN | 34.47% | $18.26B | +18.28% | 1.66% |
LMND | 34.45% | $3.11B | +168.54% | 0.00% |
CSV | 33.77% | $699.90M | +53.79% | 1.01% |
NGNE | 33.68% | $298.36M | -43.73% | 0.00% |
ETR | 33.57% | $35.39B | +53.04% | 4.26% |
DCI | 33.57% | $8.13B | -6.06% | 1.55% |
SNDX | 33.54% | $937.92M | -46.23% | 0.00% |
ABEO | 32.92% | $318.19M | +38.22% | 0.00% |
AME | 32.87% | $41.77B | +4.14% | 0.64% |
NTLA | 32.76% | $866.99M | -67.62% | 0.00% |
XENE | 32.70% | $2.48B | -15.90% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -30.55% | $21.81M | +56.22% | 0.00% |
PSQH | -16.58% | $107.02M | -32.86% | 0.00% |
WBA | -12.84% | $9.81B | -27.03% | 4.41% |
ANIK | -10.53% | $162.20M | -56.67% | 0.00% |
RPRX | -9.34% | $14.35B | +25.18% | 2.46% |
MNOV | -8.36% | $66.70M | +0.74% | 0.00% |
AQB | -6.71% | $3.52M | -50.00% | 0.00% |
OPI | -6.34% | $14.36M | -90.75% | 18.80% |
ZBH | -6.02% | $18.65B | -12.29% | 1.03% |
TSN | -6.02% | $19.34B | +1.17% | 3.60% |
CME | -5.49% | $97.17B | +37.77% | 3.95% |
VHC | -5.13% | $37.77M | +135.71% | 0.00% |
BG | -5.02% | $10.14B | -28.40% | 3.57% |
STG | -4.88% | $32.24M | -0.16% | 0.00% |
LITB | -4.63% | $21.77M | -74.81% | 0.00% |
FMTO | -4.40% | $5.10K | -99.92% | 0.00% |
PULM | -4.10% | $30.39M | +340.19% | 0.00% |
RRGB | -4.06% | $103.22M | -28.85% | 0.00% |
QNRX | -3.88% | $4.99M | -65.84% | 0.00% |
RYAN | -3.44% | $8.26B | +21.93% | 0.70% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FRO | -0.03% | $4.00B | -32.15% | 9.69% |
CMP | -0.06% | $803.28M | +57.55% | 0.00% |
PRT | 0.10% | $47.57M | +4.83% | 10.98% |
LTM | 0.11% | $12.15B | -96.20% | 2.54% |
FLNG | 0.24% | $1.28B | -11.46% | 12.54% |
AHCO | -0.27% | $1.18B | -24.05% | 0.00% |
HELE | -0.27% | $652.49M | -71.87% | 0.00% |
GENI | 0.29% | $2.32B | +81.24% | 0.00% |
SUZ | -0.32% | $11.84B | +8.25% | 0.00% |
ASC | -0.38% | $398.93M | -55.89% | 6.93% |
EPC | 0.42% | $1.19B | -34.19% | 2.40% |
NEUE | -0.44% | $60.80M | +26.11% | 0.00% |
FUBO | -0.53% | $1.15B | +169.60% | 0.00% |
MSIF | 0.56% | $831.23M | +47.01% | 6.11% |
OXBR | -0.59% | $12.50M | -25.00% | 0.00% |
ARHS | 0.62% | $1.24B | -53.72% | 0.00% |
UFI | 0.62% | $96.58M | -8.68% | 0.00% |
HUSA | 0.69% | $8.56M | -56.67% | 0.00% |
TGI | 0.69% | $2.01B | +70.60% | 0.00% |
GORV | 0.70% | $27.34M | -93.15% | 0.00% |